trial · primary record
JNJ-101684362 (HLD-0117)
Metastatic Breast Cancer
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 170 |
| Primary completion | 2030-04-15 |
| Primary endpoint | Dose Limiting Toxicities (DLTs) |
| Registry ID | NCT07524855 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:32.588Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07524855
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.